Calpain and caspase regulate Aβ peptide production via cleavage of KINDLIN2 encoded by the AD-associated gene FERMT2.

Journal: Neurobiology Of Aging
Published:
Abstract

The adapter protein KINDLIN2, encoded by the Alzheimer's disease (AD) genetic risk factor FERMT2, was identified as a modulator of APP processing. KINDLIN2 directly interacts with APP to modulate its metabolism, and KINDLIN2 underexpression impairs long-term potentiation in an APP-dependent manner. Altogether, these data suggest that loss of KINDLIN2 could have a detrimental effect on synaptic function and promote AD pathophysiological process. In this study, we identified KINDLIN2 as a novel substrate of caspases and calpain I, two well-characterized cysteine proteases involved in the regulation of synaptic plasticity. These cleavages resulted in the dissociation of the F0 and F1 domains of KINDLIN2 that are necessary for it to function as an adapter protein. Furthermore, we demonstrate that these cleavages lead to a decrease in KINDLIN2's ability to control APP processing. Overall, these KINDLIN2 cleavages appear as potential new mechanisms in the regulation of KINDLIN2 functions at the synapse and could be of interest for the pathophysiology of AD.

Authors
Chloé Najdek, Pauline Walle, Amandine Flaig, Anne-marie Ayral, Florie Demiautte, Audrey Coulon, Valérie Buiche, Philippe Amouyel, Carla Gelle, Dolores Siedlecki Wullich, Julie Dumont, Devrim Kilinc, Fanny Eysert, Jean-charles Lambert, Julien Chapuis
Relevant Conditions

Alzheimer's Disease, Dementia